PROQR THERAPEUTICS EO-04 (0PQ) — Strategic Asset Allocation Index
PROQR THERAPEUTICS EO-04 (0PQ) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of €- plus long-term investments of €0.00) total €0.00, measured against net assets of €49.37 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PROQR THERAPEUTICS EO-04 balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
PROQR THERAPEUTICS EO-04 Strategic Asset Allocation Index (2021–2025)
This chart shows how PROQR THERAPEUTICS EO-04's Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of €0.00 against net assets of €49.37 Million EUR. For live market cap and overall valuation, see 0PQ stock market capitalisation.
Annual Strategic Asset Allocation Index for PROQR THERAPEUTICS EO-04 (2021–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for PROQR THERAPEUTICS EO-04 from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See PROQR THERAPEUTICS EO-04 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | €0.00 | €- | €0.00 | €49.37 Million | ▲ +0.0 pp |
| 2024 | 0.0% | €0.00 | €- | €0.00 | €88.56 Million | ▲ +0.0 pp |
| 2023 | 0.0% | €0.00 | €- | €0.00 | €41.39 Million | ▼ -0.9 pp |
| 2022 | 0.9% | €621.00K | €- | €621.00K | €66.68 Million | ▲ +0.4 pp |
| 2021 | 0.6% | €629.00K | €- | €629.00K | €113.23 Million | — |